BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 120730)

  • 1. [A clinical study of the non-Hodgkin's lymphomas according to the Kiel classification (author's transl)].
    Stacher A; Heinz R; Waldner R
    Arch Geschwulstforsch; 1979; 49(8):715-30. PubMed ID: 120730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
    Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
    Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of malignant lymphomas of the oropharynx (author's transl)].
    Dühmke E; Schwarze EW
    HNO; 1981 Sep; 29(9):302-7. PubMed ID: 7319849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
    Wessel H
    Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects of malignant non-Hodgkin's-lymphomas with reference to Kiel classification: centrocytic lymphoma, centroblastic-centrocytic lymphoma, lymphoblastic lymphoma, immunoblastic lymphoma].
    Brittinger G; Bartels H; Bremer K; Dühmke E; Gunzer U; König E; Stein H
    Hamatol Bluttransfus; 1976; 18():211-23. PubMed ID: 786810
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of malignant lymphomas].
    Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
    Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
    Rasmuson T; Björk GR
    Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytodiagnosis of malignant non-Hodgkin's lymphomas in effusions (author's transl)].
    Wünsch PH; Müller HA
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 36(2-3):275-90. PubMed ID: 6116340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinicopathological study of non-Hodgkin's malignant lymphomas in terms of the Kiel classification.
    Takácsi-Nagy L; Tarkovács G; Szende B; Gráf F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):79-92. PubMed ID: 77823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-grading of malignant lymphomas. II. Correlation with clinical parameters.
    Böcking A; Chatelain R; Auffermann W; Löhr GW; Reif M; Rossner R; Becker H
    Anticancer Res; 1986; 6(5):1217-23. PubMed ID: 3800328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical manifestations of histologically classified malignant lymphomas in the ENT area].
    Zwirner P; Grevers G; Wilmes E
    Laryngorhinootologie; 1990 Dec; 69(12):642-6. PubMed ID: 2288627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical data and therapy of malignant non-Hodgkin's lymphoma of nasal cavity and paranasal sinuses (author's transl)].
    Löbe LP; Katenkamp D
    Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):334-7. PubMed ID: 6894956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Involvement of the central nervous system in generalized non-Hodgkin's lymphomas (author's transl)].
    Gerlach H; Jänisch W; Schreiber D; Feist H; Wessel H
    Arch Geschwulstforsch; 1980; 50(1):1-10. PubMed ID: 7447626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant non-Hodgkin lymphomas--a review].
    Bruntsch U
    HNO; 1985 Nov; 33(11):481-4. PubMed ID: 4077587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant lymphomas--review, classification and staging].
    Pfannmüller E
    Rontgenblatter; 1984 Feb; 37(2):46-50. PubMed ID: 6710028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-Hodgkin's malignant lymphomas. Clinico-pathological data and course in 370 patients (author's transl)].
    Lagarde C; Hoerni B; de Mascarel A; Meugé C; Richaud P; Durand M; Eghbali H; Hoerni-Simon G; le Treut A; Chauvergne J
    Bull Cancer; 1980; 67(2):139-48. PubMed ID: 7448435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of non-hodgkin's lymphomas (author's transl)].
    Fereberger W; Neubauer M
    Acta Med Austriaca; 1981; 8(1):1-6. PubMed ID: 7234308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.